BAP1 and mesothelioma: If our ongoing preclinical studies of sulforaphane in asbestos-exposed Bap1-mutant mice are successful, they will help inform the design of a preventive regimen for occupationally exposed asbestos workers at increased risk for mesothelioma and populations residing in areas heavily contaminated with asbestos, erionite, or other EMPs.